Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amyris Inc (AMRS)

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
4 Cannabis Stocks With the Runway Necessary to Reach New Highs

Cannabis is increasingly becoming accepted, and the market is growing. More states are legalizing it for medicinal and recreational purposes. New companies are emerging to serve this market. A potential,...

AMRS : 2.71 (+2.65%)
TPB : 28.54 (+0.60%)
VFF : 4.84 (+1.26%)
NEPT : 2.15 (-0.46%)
Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural...

AMRS : 2.71 (+2.65%)
Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural...

AMRS : 2.71 (+2.65%)
Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural...

AMRS : 2.71 (+2.65%)
LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation

, /PRNewswire/ -- LAVVAN, Inc. ("LAVVAN") today announced that it has filed an lawsuit against biotechnology company Amyris, Inc. ("Amyris") (Nasdaq: AMRS) relating to Amyris's use of intellectual property...

AMRS : 2.71 (+2.65%)
Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
New Strong Sell Stocks for September 4th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

AMRS : 2.71 (+2.65%)
EMAN : 1.1700 (-4.88%)
ASPS : 12.02 (-2.28%)
HESM : 15.14 (-1.05%)
ITMR : 21.61 (+2.03%)
Amyris Scales First Fermentation-Based Cannabinoid

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Users Marvel at Medical Cannabis' Myriad of Applications

, /PRNewswire/ -- Over the past several years, the cannabis industry has reached several milestones to almost completely redefine itself. Now, medical cannabis is predominantly being used to alleviate...

APHA : 4.23 (+0.24%)
MEDIF : 0.6398 (+6.46%)
LABS.TO : 0.84 (+5.00%)
NEPT.TO : 2.89 (unch)
AMRS : 2.71 (+2.65%)
ACB : 5.05 (-2.88%)
ACB.TO : 6.78 (-1.88%)
APHA.TO : 5.66 (+0.71%)
Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Amyris, Inc. Reports Second Quarter 2020 Results

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Cannabis Sales Surge During Lock Down

, /PRNewswire/ --  As the pandemic wreaked havoc on the U.S. and global economies, cannabis sales rocketed higher across multiple markets in North America. California nearly 160% compared to the same...

VFF : 4.84 (+1.26%)
HEXO : 0.6584 (+2.11%)
AMRS : 2.71 (+2.65%)
TLRY : 4.79 (+0.84%)
NUGS : 0.0619 (+3.17%)
Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE(TM) Sweetener

The exclusive multi-year agreement is expected to transform the industrial baking sector in the US, Mexico and Canada markets

AMRS : 2.71 (+2.65%)
Positive First Steps Show the Promise of Psychedelic Therapies

, /PRNewswire/ -- Depression and PTSD are serious psychiatric disorders which happen to share some similar symptoms. Either disorder might cause trouble sleeping, anger over little things, or a loss...

ACB.TO : 6.78 (-1.88%)
NLBIF : 0.6150 (-6.82%)
MYCO.CN : 0.285 (+35.71%)
NEPT.TO : 2.89 (unch)
AMRS : 2.71 (+2.65%)
Amyris Announces Closing Of $200 Million Private Placement

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Thinking about buying stock in Dolphin Entertainment, Mereo BioPharma, Amyris Inc, JetBlue Airways, or FuelCell Energy?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DLPN, MREO, AMRS, JBLU, and FCEL.

AMRS : 2.71 (+2.65%)
Amyris Raises $200 Million From Private Placement

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Studies Into Psychedelic Drugs Reveal Significant Medical Potential

, /PRNewswire/ -- Psychedelic drugs include a range of substances with varying pharmacological profiles that all have strong effects on the consumer's conscious experience. Such products are borne from...

AMRS : 2.71 (+2.65%)
VFF : 4.84 (+1.26%)
ZYNE : 3.28 (+1.55%)
NUMI.VN : 0.285 (+18.75%)
LKYSD : 0.3330 (+17.54%)
VFF.TO : 6.44 (+1.26%)
NEPT.TO : 2.89 (unch)
Psychedelics Seek to Emulate Cannabis' Rise to Social Acceptance

, /PRNewswire/ -- There have been several important developments in the psychedelics market in recent years that indicate a change in public sentiment around such products. For example, earlier this year,...

VFF : 4.84 (+1.26%)
AMRS : 2.71 (+2.65%)
SPRWF : 0.1138 (+4.60%)
TCNNF : 18.1700 (+6.74%)
NLBIF : 0.6150 (-6.82%)
NLB.CN : 1.000 (+12.36%)
VFF.TO : 6.44 (+1.26%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar